partners & collaborators

Santaris Pharma A/S® is the industry leader and preferred partner for the development of mRNA- and microRNA-targeted medicines. We have partnered with recognized industry leaders to leverage our antisense chemistry and deliver on the promise of RNA therapeutics. These partnerships further validate the broad utility of our LNA Drug Platform and Drug Discovery Engine to develop transformational therapeutics across multiple disease areas.

We use our proven chemistry and expertise to design and select lead drug candidates for our partners. Our partners receive superior drug candidates for further development to which the partners enjoy worldwide commercial rights. Current collaborations include development projects and agreements with: Bristol-Myers Squibb, GlaxoSmithKline, Isarna, miRagen, Pfizer, RaNA, Roche, and Shire.

For more information about partnering and collaborating with Santaris, please contact:

Henrik Ørum
CSO & VP Business Development
Tel: +45 4517 9800